Cited by 2Breast Cancer Treatment StudiesTelomeres, Telomerase, and SenescenceMultiple and Secondary Primary Cancers

The DOI matches its Crossref record.

Biomarkers of aging associated with past treatments in breast cancer survivors: when therapy-induced pathways turn out to be potential therapeutic targets

Open access
Jabbour, Wafaa, Wion, Didier·2018·npj Breast Cancer

Abstract

In a recent paper in NPJ Breast Cancer , Scuric et al. 1 found that in breast cancer patients, chemotherapy and radiation exposure were associated with some biomarkers of aging in white blood cell (WBC) and in peripheral blood mononuclear cells (PBMCs). Elevated levels of sTNF-RII, a biomarker of pro-inflammatory activation, were also detected. These results were obtained 3–6 years after the completion of primary treatments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41523-018-0058-6

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 10

  1. Scuric, Z. et al. Biomarkers of aging associated with past treatments in breast cancer survivors. NPJ Breast Cancer 3, 50 (2017). · DOI
  2. Schwartz, C. L. Long-term survivors of childhood cancer: the late effects of therapy. Oncologist 4, 45–54 (1999). · DOI
  3. Barcellos-Hoff, M. H., Park, C. & Wright, E. G. Radiation and the microenvironment - tumorigenesis and therapy. Nat. Rev. Cancer 5, 867–875 (2005). · DOI
  4. Sharma, V. et al. Oxidative stress at low levels can induce clustered DNA lesions leading to NHEJ mediated mutations. Oncotarget 7, 25377–25390 (2016). · DOI
  5. Lorimore, S. A., McIlrath, J. M., Coates, P. J. & Wright, E. G. Chromosomal instability in unirradiated hemopoietic cells resulting from a delayed in vivo bystander effect of gamma radiation. Cancer Res. 65, 5668–5673 (2005). · DOI
  6. Basil, M. C. & Levy, B. D. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat. Rev. Immunol. 16, 51–67 (2016). · DOI
  7. Bonavita, E., Pelly, V. S. & Zelenay, S. Resolving the dark side of therapy-driven cancer cell death. J. Exp. Med. 215, 9–11 (2018). · DOI
  8. Sulciner, M. L. et al. Resolvins suppress tumor growth and enhance cancer therapy. J. Exp. Med. 215, 115–140 (2018). · DOI
  9. Ratel, D., van der Sanden, B. & Wion, D. Glioma resection and tumor recurrence: back to Semmelweis. Neuro-Oncology 18, 1688–1689 (2016). · DOI
  10. Demicheli, R., Retsky, M. W., Hrushesky, W. J. M., Baum, M. & Gukas, I. D. The effects of surgery on tumor growth: a century of investigations. Ann. Oncol. 19, 1821–1828 (2008). · DOI

Cited by

Sorted by citations

Metadata

Authors
Jabbour, W., & Wion, D.
Affiliations
Inserm (FR)
Corresponding author
Wion, Didier
Venue
npj Breast Cancer
Published
2018-03-06
Volume
4
Issue
1
Pages
4-4
ISSN
2374-4677 (ISSN-L)
OpenAlex
W2790400829
Cited by
2
References
0
Citations by year
2022: 1 · 2020: 1
FWCI
0.08
Type
journal article
Language
en
Open access
Locations
  • npj Breast Cancer (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Epidemiology › Multiple and Secondary Primary Cancers
Keywords
aging biomarkers, breast cancer survivors, chemotherapy, radiotherapy, peripheral blood mononuclear cells, leukocytes, inflammation, therapeutic target, late effects of cancer treatment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review